Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations

Author:

Pahuja Kanika Bajaj,Nguyen Thong T.,Jaiswal Bijay S.,Prabhash Kumar,Thaker Tarjani M.,Senger Kate,Chaudhuri Subhra,Kljavin Noelyn M.,Antony Aju,Phalke Sameer,Kumar Prasanna,Mravic Marco,Stawiski Eric W.,Vargas Derek,Durinck Steffen,Gupta Ravi,Khanna-Gupta Arati,Trabucco Sally E.,Sokol Ethan S.,Hartmaier Ryan J.,Singh Ashish,Chougule Anuradha,Trivedi Vaishakhi,Dutt Amit,Patil Vijay,Joshi Amit,Noronha Vanita,Ziai James,Banavali Sripad D.,Ramprasad Vedam,DeGrado William F.,Bueno Raphael,Jura Natalia,Seshagiri Somasekar

Funder

National Institute of General Medical Sciences

Susan G. Komen Foundation Career

National Cancer Institute

HHMI

UCSF

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference78 articles.

1. A global reference for human genetic variation;1000 Genomes Project Consortium;Nature,2015

2. Germ-line expression of an oncogenic erbB2 allele confers resistance to erbB2-induced mammary tumorigenesis;Andrechek;Proc. Natl. Acad. Sci. U S A,2004

3. Architecture and membrane interactions of the EGF receptor;Arkhipov;Cell,2013

4. Treatment of HER2-positive breast cancer: current status and future perspectives;Arteaga;Nat. Rev. Clin. Oncol.,2011

5. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline;Van der Auwera;Curr. Protoc. Bioinformatics,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3